Global Large volume wearable injectors Market Research Report 2019-2030


Posted August 5, 2020 by charlottefraser21

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

 
The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting in significant efforts to develop efficient and effective drug-device combinations to deliver large volumes of drugs over a convenient period of time.

The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin and of non-insulin drugs, respectively, has been analyzed across the following segments:

Type of Device
• Patch Pump / Injectors
• Infusion Pump / Injectors

Product Usability
• Disposable
• Re-usable

Therapeutic Area (for non-insulin drugs)
• Neurological Disorders
• Cardiovascular Disorders
• Oncological Disorders
• Infectious Disorders

Key geographical regions
• North America
• Europe
• Asia Pacific

The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices features the following companies, which we identified to be key players in this domain:

• Becton Dickinson
• Bespak (subsidiary of Consort Medical)
• CeQur
• Debiotech
• Eli Lilly
• Enable Injections
• Insulet
• Medtronic
• PharmaSens
• Roche
• SOOIL Development
• Sonceboz
• Sensile Medical (acquired by Gerresheimer)
• SteadyMed Therapeutics (acquired by United Therapeutics)
• Tandem Diabetes Care
• Weibel CDS (acquired by SHL Medical)
• West Pharmaceutical Services

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Large Volume Wearable Injectors: Current Market Landscape
5. Product Competitiveness Analysis
6. Large Volume Wearable Injectors: Key Players
7. Drug Device Combinations: Tabulated Profiles
8. Partnerships and Collaborations
9. Key Acquisition Targets
10. Patent Analysis
11. Large Volume Wearable Injectors: Likely Drug Candidates
12. Emerging Trends on Social Media
13. Clinical Trial Analysis
14. Case Study: Role of CMOs in Device Development and Manufacturing
15. Regulatory and Reimbursement Landscape for Medical Devices
16. Market Sizing and Opportunity Analysis
17. SWOT Analysis
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Phone 4158003415
Business Address Sacramento Los Angeles Beverly Hills
Country United States
Categories Business , Industry , Medical
Tags large volume wearable injectors , large volume wearable injectors market , large volume wearable injectors market size
Last Updated August 5, 2020